إعلان
إعلان
TVRD
T
Tvardi Therapeutics, Inc. Common Stock
4.24
USDبرعاية
+0.35
+9.00%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
4.24
0.00
0.00%
تقارير أرباح TVRD
النسبة الإيجابية المفاجئة
TVRD تفوق 20 من 39 آخر التقديرات.
51%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.65
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+10.17%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/--
Tvardi Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, TVRD reported earnings of -0.59 USD per share (EPS) for Q3 25, beating the estimate of -1.01 USD, resulting in a 42.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.95% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.65 USD, with revenue projected to reach -- USD, implying an زيادة of 10.17% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Tvardi Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Tvardi Therapeutics, Inc. Common Stock reported EPS of -$0.59, beating estimates by 42.14%, and revenue of $0.00, 0% as expectations.
How did the market react to Tvardi Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.95%, changed from $4.11 before the earnings release to $4.03 the day after.
When is Tvardi Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Tvardi Therapeutics, Inc. Common Stock's next earnings report?
Based on 10
المحللين, Tvardi Therapeutics, Inc. Common Stock is expected to report EPS of -$0.65 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان